doxazosin

Generic: doxazosin

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin
Labeler aphena pharma solutions - tennessee, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 8 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-831
Product ID 71610-831_187bc466-9b63-4ac5-e063-6294a90a7e9b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208719
Listing Expiration 2026-12-31
Marketing Start 2017-08-31

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610831
Hyphenated Format 71610-831

Supplemental Identifiers

RxCUI
197628
UNII
86P6PQK0MU

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin (source: ndc)
Application Number ANDA208719 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 8 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (71610-831-53)
  • 90 TABLET in 1 BOTTLE (71610-831-60)
source: ndc

Packages (2)

71610-831-53 60 TABLET in 1 BOTTLE (71610-831-53) 71610-831-60 90 TABLET in 1 BOTTLE (71610-831-60)

Ingredients (1)

doxazosin mesylate (8 mg/1)

Linked Drug Pages (1)

Doxazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "187bc466-9b63-4ac5-e063-6294a90a7e9b", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197628"], "spl_set_id": ["187bc51b-7a3a-5910-e063-6294a90aa888"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71610-831-53)", "package_ndc": "71610-831-53", "marketing_start_date": "20240513"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-831-60)", "package_ndc": "71610-831-60", "marketing_start_date": "20240513"}], "brand_name": "Doxazosin", "product_id": "71610-831_187bc466-9b63-4ac5-e063-6294a90a7e9b", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "71610-831", "generic_name": "Doxazosin", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "8 mg/1"}], "application_number": "ANDA208719", "marketing_category": "ANDA", "marketing_start_date": "20170831", "listing_expiration_date": "20261231"}